GZGuanghao Zheng

Guanghao Zheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guanghao Zheng has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Preoperative risk stratification for long-term neurological status in spinal ependymoma: an MRI-centered nomogram

    by Bo Wang, Weihao Liu, Chong Wang, Kai Ji, Yaowu Zhang, Guanghao Zheng, Xingyu Liu, Tianyi Zhang, Yixiang Liu, Ting Sun, et al.

    Purpose Despite favorable long-term survival in WHO grade 2 spinal ependymoma, long-term neurological impairment remains clinically important. This study aimed to develop an MRI-centered preoperative nomogram for individualized prediction of long-term unfavorable neurological status. Methods This retrospective study included 582 patients with histopathologically confirmed WHO grade 2 spinal ependymoma. Long-term neurological status was assessed using the modified McCormick Scale (MMS), with final MMS > II defined as unfavorable status. Candidate preoperative predictors were evaluated using univariable logistic regression and collinearity diagnostics. The final model incorporated preoperative MMS and five routinely available MRI predictors: tumor-to-cord ratio, tumor location, intratumoral hemorrhage, peripheral edema, and MRI classification. Model performance was assessed using discrimination, calibration, bootstrap internal validation, and decision curve analysis. Results Among 582 patients, 120 had unfavorable neurological status at final follow-up. The final MRI-centered model showed good discrimination, with an apparent AUC of 0.818 (95% CI, 0.776–0.859) and an optimism-corrected AUC of 0.797 after 1000 bootstrap resamples. Calibration analysis showed satisfactory agreement between predicted and observed probabilities, with a Brier score of 0.125. Decision curve analysis demonstrated positive net benefit over an approximate threshold range of 0.01–0.66. Conclusion An MRI-centered preoperative nomogram integrating preoperative MMS and routinely available MRI predictors may support individualized risk stratification in patients with WHO grade 2 spinal ependymoma. This tool may assist preoperative counseling and risk-informed surgical planning, although external validation is required before broader clinical implementation.

  • Intraoperative shear wave elastography during surgical treatment of intramedullary spinal cord tumors

    by Kai Ji, Lin-Yu Xu, Bo Wang, Chong Wang, Guang-Hao Zheng, Wei-Hao Liu, Yao-Wu Zhang, Yi-Xiang Liu, Xing-Yu Liu, Bo Han, et al.

  • Open Access

    Multi-omics analysis delineates molecular signatures of spinal ependymal tumor

    by Weihao Liu, Chao Ning, Xiaohan Geng, Bo Wang, Yaowu Zhang, Chong Wang, Yixiang Liu, Guanghao Zheng, Yongzhi Wang, Xinyu Wang, et al.

    Background: Spinal ependymal tumors are a diverse group of neoplasms encompassing four subtypes: spinal ependymoma (SP-EPN), spinal ependymoma, MYCN -amplification (SP-EPN- MYCN ), spinal myxopapillary ependymoma (SP-MPE), and spinal subependymoma (SP-SE). However, the molecular differences among these subtypes remain largely unknown. Methods: Using an integrated multi-omics approach (whole-genome sequencing, RNA-seq, and mass spectrometry), we identified the distinct molecular characteristics of three subtypes except for SP-EPN- MYCN . Results: In SP-EPN, abnormal enrichment of ciliary signaling, particularly involving the MKS complex, was evident. SP-MPE exhibited significant dysregulation of mitochondrial metabolism, reflecting a metabolic profile aligned with the Warburg effect. SP-SE tumors showed enhanced activity of immune-related pathways, including interferon signaling and extracellular vesicle dynamics, suggesting a distinct tumor microenvironment. Conclusion: This pilot study identifies candidate molecular markers in a single-center spinal ependymal tumor cohort. Clinical trial number: Not applicable.